Catalyst Wire Dossier Catalyst Wire Dossier

Alogliptin/Pioglitazone (Liovel) Combination Tablets

Alogliptin Pioglitazone · Takeda
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Alogliptin/Pioglitazone (Liovel) Combination Tablets, covering 2019-01-18 to 2019-01-18. Get the full timeline:

Most recent: Clinical Trial Update: Alogliptin/Pioglitazone (Liovel) Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus

See pricing